Shopko Optical 129 | |
4515 S Regal St, Spokane, WA 99223-7938 | |
(509) 448-9686 | |
Not Available |
Full Name | Shopko Optical 129 |
---|---|
Type | Facility |
Speciality | Eyewear Supplier |
Location | 4515 S Regal St, Spokane, Washington |
Accepts Medicare Assignments | Does not participate in Medicare Program. The facility may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1023060050 | NPI | - | NPPES |
G8855122 | Other | MEDICARE | |
014129 | Other | VIP | |
CP2230-59 | Other | EYEMED | |
WA09203 | Other | WA | NORIDIAN SUBMITTER ID |
2017622 | Medicaid | WA | |
42549 | Other | DAVIS VISION | |
10831 | Other | MEDICARE | |
2017218 | Medicaid | WA | |
35548 | Other | AVESIS |
Mailing Address | Practice Location Address |
---|---|
Shopko Optical 129 4515 S Regal St, Spokane, WA 99223-7938 Ph: (509) 448-9686 | Shopko Optical 129 4515 S Regal St, Spokane, WA 99223-7938 Ph: (509) 448-9686 |
News Archive
The company GB Sciences Inc. has obtained the exclusive global worldwide intellectual property license for this innovative solution, which is based on nanotechnology.
An inquiry led by the BBC has found that nine out of ten NHS hospitals have asbestos. The inquiry included 211 trust hospitals of which 198 agreed that they used asbestos in their hospital.
After decades investigating a rare, life-threatening condition that cripples the muscles, Duke Health researchers have developed a gene therapy they hope could enhance or even replace the only FDA-approved treatment currently available to patients.
Proteins produced by cancer cells are among the common targets for anticancer agents, and thanks to efforts in proteomics and cancer genomics, the number of potential protein targets is increasing exponentially.
› Verified 1 days ago